Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Strata Critical MedicalSRTA +2.87%74 Equity-to-Asset is 0.84 as of Jun. 2026, which is 1% below its 10-year median of 0.85. GuruFocus rates SRTA with a GF Score™ of 74/100 and a GF Value™ of $4.85 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 687 Healthcare Providers & Services companies, Strata Critical Medical ranks better than 89.08% on this metric.
The historical rank and industry rank for Strata Critical Medical's Equity-to-Asset or its related term are showing as below:
SRTA'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.63 Med: 0.85 Max: 0.9
Current: 0.84
During the past 5 years, the highest Equity to Asset Ratio of Strata Critical Medical was 0.90. The lowest was 0.63. And the median was 0.85.
SRTA's Equity-to-Asset is ranked better than 89.08% of 687
companies
in the Healthcare Providers & Services industry
Industry Median: 0.49
vs SRTA: 0.84
Strata Critical Medical (NAS:SRTA) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Strata Critical Medical Equity-to-Asset Related Terms
Strata Critical Medical Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SRTA vs STLN, CYH, AUNA: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Strata Critical Medical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Strata Critical Medical Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Strata Critical Medical's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Strata Critical Medical's Equity-to-Asset falls into.
Strata Critical Medical Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Strata Critical Medical's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Strata Critical Medical (SRTA) has a Equity-to-Asset of 0.84 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Strata Critical Medical and its competitors. This is near median its historical median of 0.85. Over the past decade, Strata Critical Medical's Equity-to-Asset has ranged from 0.63 to 0.90. According to the industry distribution chart, Strata Critical Medical ranks #75 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 10.9%.
Is Strata Critical Medical's Equity-to-Asset too high?
Strata Critical Medical's current Equity-to-Asset of 0.84 is near median its 10-year median of 0.85. Over the past 10 years, this metric has ranged from a low of 0.63 to a high of 0.90. The Healthcare Providers & Services industry median Equity-to-Asset is 0.49. Strata Critical Medical's value of 0.84 is 71.4% above this industry median. Based on the distribution chart, Strata Critical Medical ranks #75 out of 687 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Strata Critical Medical has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Strata Critical Medical's Equity-to-Asset compare to STLN and CYH?
According to the Healthcare Providers & Services industry distribution chart, Strata Critical Medical ranks #75 out of 687 companies for Equity-to-Asset. This places Strata Critical Medical in the top 11% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.49. Strata Critical Medical's value of 0.84 is 71.4% above this benchmark. Historically, Strata Critical Medical's own Equity-to-Asset has ranged from 0.63 to 0.90 over the past decade. While the company's 10-year median is 0.85 vs. the industry median of 0.49, Strata Critical Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Strata Critical Medical's current Equity-to-Asset of 0.84 is 71.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Strata Critical Medical and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Strata Critical Medical's current Equity-to-Asset is 0.84, which is near median its own 10-year median of 0.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strata Critical Medical stock overvalued right now?
Based on GuruFocus' analysis, Strata Critical Medical (SRTA) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.85, compared to a current price of $5.38 — trading 10.9% above its estimated fair value. The current Equity-to-Asset is 0.84, which is near median its 10-year median of 0.85 and 71.4% above the Healthcare Providers & Services industry median of 0.49. Strata Critical Medical's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Strata Critical Medical (SRTA), the current Equity-to-Asset is 0.84 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Strata Critical Medical (SRTA) Overvalued in 2026?
Based on GuruFocus' analysis, Strata Critical Medical stock appears to be overvalued.
The current stock price of $5.38 is trading 10.9% above its estimated GF Value™ of $4.85.
GuruFocus considers Strata Critical Medical to be Modestly Overvalued.
Key valuation signals for SRTA:
Equity-to-Asset: 0.84 (near median its 10-year median of 0.85)
GF Value™: $4.85 vs. price of $5.38 (10.9% above fair value)
Industry Position: 71.4% above the Healthcare Providers & Services median (#75 of 687)
No single metric tells the full story. See the SRTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
74GF Score
Get the complete analysis for SRTA
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRTA has been successfully added to your 
